Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ONCT - Oncternal Therapeutics: Opportunistic Investment In A ROR-1 Biotech

ONCT - Oncternal Therapeutics: Opportunistic Investment In A ROR-1 Biotech

Oncternal Therapeutics Inc.
  • Oncternal Therapeutics is one of the few companies with clinical assets targeting ROR-1.
  • Recent M&As for two ROR-1 companies by Merck and Boehringer Ingelheim have set a market value around $1B-$2B.
  • With upcoming clinical catalysts for their lead drug candidate, Oncternal is an opportunistic investment in a potential M&A over the next year or so.

For further details see:

Oncternal Therapeutics: Opportunistic Investment In A ROR-1 Biotech
Stock Information
Company Name: Oncternal Therapeutics Inc.
Stock Symbol: ONCT
Market: NASDAQ
Website: oncternal.com
Menu
ONCT ONCT Quote ONCT Short ONCT News ONCT Articles ONCT Message Board
Get ONCT Alerts

News, Short Squeeze, Breakout and More Instantly...